MedTrace Logo

Prevalence of Factors Contributing to Unplanned Hospital Readmission of Older Medical Patients

NCT05116644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2023-09-25

No results posted yet for this study

Summary

We need to identify the essential factors that are linked to readmission among older medical patients as approximately 20% of all medical patients above the age of 65 are readmitted within 30 days after discharge.

The objective of this cross-sectional survey study is to to identify factors and aspects that contribute to unplanned hospital readmissions of older medical patients.

This will be done through a survey where readmitted patients and their relatives and healthcare professionals answer questions about the patients readmission. The survey questions cover following themes: 1) disease, 2) diagnostics, treatment and care, 3) social network, 4) organisation, 5) communication, 6) competences and knowledge, 7) resources and 8) practical aspects. The hypothesis is that the more knowledge we gain on factors that contribute to readmission, the more targeted actions and interventions and thus preventing readmissions.

Conditions

  • Readmission

Interventions

OTHER

NONE - this is a cross-sectional survey design

NONE - this is a cross-sectional survey design

Sponsors & Collaborators

  • Enversion

    collaborator UNKNOWN

  • Central Denmark Region

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Merete Gregersen, PhD · Aarhus University, Aarhus Uviversity Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2021-06-25
Completion
2021-06-25

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05116644 on ClinicalTrials.gov